Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Study Information
Alliance Study ID: CALGB-119802
NCT Study ID (ClinicalTrials.gov): NCT00005850
Alliance Committee: Respiratory Cancer
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Donna Greenberg, MD
Status: COMPLETED
Study Description
This trial is designed to test the efficacy of fluoxetine to improve patient’s quality of life during chemotherapy. An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information